Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (154) 154
life sciences & biomedicine (141) 141
humans (115) 115
oncology (83) 83
female (73) 73
male (68) 68
adult (57) 57
middle aged (57) 57
glioblastoma (56) 56
neurosciences & neurology (53) 53
aged (51) 51
clinical neurology (45) 45
tumors (45) 45
glioma (36) 36
brain neoplasms - drug therapy (34) 34
neurology (33) 33
biological and medical sciences (28) 28
brain tumors (28) 28
prognosis (28) 28
gliomas (27) 27
medical sciences (27) 27
apoptosis (26) 26
chemotherapy (25) 25
hypoxia (25) 25
animals (24) 24
brain neoplasms - pathology (24) 24
cancer (24) 24
care and treatment (24) 24
glioblastoma - drug therapy (24) 24
patients (24) 24
neurosciences (23) 23
bevacizumab (22) 22
brain neoplasms - metabolism (22) 22
brain neoplasms - mortality (22) 22
glioblastoma - pathology (22) 22
biochemistry & molecular biology (21) 21
brain cancer (21) 21
cell line, tumor (21) 21
glioblastoma - mortality (21) 21
glioma - metabolism (21) 21
medicine & public health (21) 21
analysis (20) 20
glioblastoma multiforme (20) 20
610 medicine & health (19) 19
disease-free survival (19) 19
magnetic resonance imaging (19) 19
mice (19) 19
glioma - pathology (18) 18
metabolism (18) 18
treatment outcome (18) 18
brain neoplasms - genetics (17) 17
follow-up studies (17) 17
glioma - drug therapy (17) 17
young adult (17) 17
medical prognosis (16) 16
survival (16) 16
survival rate (16) 16
aged, 80 and over (15) 15
dna methylation (15) 15
glioblastoma - genetics (15) 15
tumor suppressor proteins - genetics (15) 15
dacarbazine - analogs & derivatives (14) 14
dna modification methylases - genetics (14) 14
dna repair enzymes - genetics (14) 14
mutation (14) 14
neoplasm recurrence, local - drug therapy (14) 14
pathology (13) 13
prospective studies (13) 13
proteins (13) 13
radiation therapy (13) 13
tumors of the nervous system. phacomatoses (13) 13
antineoplastic agents (12) 12
cancer therapies (12) 12
cell biology (12) 12
cell death (12) 12
clinic for neurology (12) 12
temozolomide (12) 12
biomarkers (11) 11
brain (11) 11
brain neoplasms - diagnosis (11) 11
brain neoplasms - therapy (11) 11
combined modality therapy (11) 11
genetic aspects (11) 11
glucose (11) 11
health aspects (11) 11
kinases (11) 11
phosphorylation (11) 11
survival analysis (11) 11
abridged index medicus (10) 10
adolescent (10) 10
brain - pathology (10) 10
chemistry (10) 10
glucose - metabolism (10) 10
medical research (10) 10
neoplasm staging (10) 10
physical sciences (10) 10
radiology, nuclear medicine & medical imaging (10) 10
research (10) 10
research article (10) 10
retrospective studies (10) 10
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Knockdown of the TP53-induced glycolysis and apoptosis regulator (TIGAR) sensitizes glioma cells to hypoxia, irradiation and temozolomide
by Maurer, Gabriele D and Heller, Sonja and Wanka, Christina and Rieger, Johannes and Steinbach, Joachim P
International journal of molecular sciences, ISSN 1661-6596, 03/2019, Volume 20, Issue 5, p. 1061
Reactive oxygen species | Glioma | TP53-induced glycolysis and apoptosis regulator | Hypoxia-inducible factor | Irradiation | Hypoxia | Temozolomide | Biochemistry & Molecular Biology | Physical Sciences | Chemistry | Life Sciences & Biomedicine | Chemistry, Multidisciplinary | Science & Technology | Humans | Radiation Tolerance | Drug Resistance, Neoplasm | Intracellular Signaling Peptides and Proteins - metabolism | Antineoplastic Agents - toxicity | Glioma - metabolism | Cell Hypoxia | Apoptosis Regulatory Proteins | Cell Line, Tumor | Neurons - metabolism | Neurons - drug effects | Neurons - radiation effects | Intracellular Signaling Peptides and Proteins - genetics | Temozolomide - toxicity | Adenocarcinoma | Flow cytometry | Oxidative stress | p53 Protein | Leukemia | Brain cancer | Lung cancer | DNA damage | Colorectal carcinoma | Radiation | Metastasis | Cancer therapies | Metastases | Genomic instability | Glioma cells | Oxidation | Pancreas | Deoxyribonucleic acid--DNA | Glutathione | Level (quantity) | Metabolism | Gene silencing | Chemotherapy | Cell death | Glycolysis | Apoptosis | Tumors | Index Medicus | temozolomide | hypoxia | reactive oxygen species | glioma | hypoxia-inducible factor | irradiation
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Tp53-induced glycolysis and apoptosis regulator (TIGAR) protects glioma cells from starvation-induced cell death by up-regulating respiration and improving cellular redox homeostasis
by Wanka, Christina and Steinbach, Joachim P and Rieger, Johannes
The Journal of biological chemistry, ISSN 0021-9258, 09/2012, Volume 287, Issue 40, pp. 33436 - 33446
Life Sciences & Biomedicine | Biochemistry & Molecular Biology | Science & Technology | Cell Line | Reactive Oxygen Species | Oxidation-Reduction | Humans | Gene Expression Regulation | Gene Expression Regulation, Neoplastic | Oxygen Consumption | Intracellular Signaling Peptides and Proteins - metabolism | Brain Neoplasms - metabolism | Tumor Suppressor Protein p53 - genetics | Glioma - metabolism | Hypoxia - metabolism | Phosphoric Monoester Hydrolases | Animals | Apoptosis Regulatory Proteins | Models, Biological | Cell Death | Cell Line, Tumor | Glycolysis | Mice | Intracellular Signaling Peptides and Proteins - physiology | Pentose Phosphate Pathway | Apoptosis | Index Medicus | TIGAR | Glioma | Cell Metabolism | Pentose Pathway | Hypoxia | Metabolism | p53
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Rescue of 2-deoxyglucose side effects by ketogenic diet
by Voss, Martin and Lorenz, Nadja I and Luger, Anna-Luisa and Steinbach, Joachim P and Rieger, Johannes and Ronellenfitsch, Michael W
International journal of molecular sciences, ISSN 1661-6596, 08/2018, Volume 19, Issue 8, p. 2462
Glycolysis | Isocaloric ketogenic diet | Metabolic cancer therapy | 2-deoxyglucose (2-DG) | Warburg effect | Biochemistry & Molecular Biology | Physical Sciences | Chemistry | Life Sciences & Biomedicine | Chemistry, Multidisciplinary | Science & Technology | Neoplasms - metabolism | Diet, Ketogenic - methods | Ketone Bodies - metabolism | Ketosis - etiology | Glycolysis - drug effects | Antimetabolites - administration & dosage | Antimetabolites - adverse effects | Animals | Deoxyglucose - adverse effects | Mice, Nude | Deoxyglucose - administration & dosage | Glucose - metabolism | Female | Ketosis - metabolism | Blood Glucose - metabolism | Carbohydrates | Therapy | Ketogenesis | Ketone bodies | Glucose | Metabolism | Deoxyglucose | High fat diet | Proteins | Side effects | Low carbohydrate diet | Diet | Mice | Cancer | Phosphorylation | Alternative energy | Brain cancer | Kinases | Cancer therapies | Hyperglycemia | Drug dosages | Radiation therapy | Hypoglycemia | Chemotherapy | Hypoxia | Apoptosis | Tumors | Index Medicus | isocaloric ketogenic diet | metabolic cancer therapy | glycolysis
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Differential utilization of ketone bodies by neurons and glioma cell lines: A rationale for ketogenic diet as experimental glioma therapy
by Maurer, Gabriele D and Brucker, Daniel P and Bähr, Oliver and Harter, Patrick N and Hattingen, Elke and Walenta, Stefan and Mueller-Klieser, Wolfgang and Steinbach, Joachim P and Rieger, Johannes
BMC cancer, ISSN 1471-2407, 07/2011, Volume 11, Issue 1, pp. 315 - 315
Life Sciences & Biomedicine | Oncology | Science & Technology | NIH 3T3 Cells | Rats, Wistar | Humans | Ketone Bodies - metabolism | Immunoblotting | Neurons - cytology | Glioma - diet therapy | Glioma - metabolism | Hydroxybutyrate Dehydrogenase - genetics | Coenzyme A-Transferases - genetics | Glioma - pathology | Female | Neurons - metabolism | Animals, Newborn | Cell Survival - drug effects | Diet, Ketogenic | Cells, Cultured | Rats | Glucose - pharmacology | Reverse Transcriptase Polymerase Chain Reaction | Acetyl-CoA C-Acetyltransferase - genetics | Hydroxybutyrate Dehydrogenase - metabolism | Xenograft Model Antitumor Assays | Coenzyme A-Transferases - metabolism | Animals | Mice, Nude | 3-Hydroxybutyric Acid - metabolism | Cell Line, Tumor | Glucose - metabolism | Mice | 3-Hydroxybutyric Acid - pharmacology | Acetyl-CoA C-Acetyltransferase - metabolism | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Antagonism of the mammalian target of rapamycin selectively mediates metabolic effects of epidermal growth factor receptor inhibition and protects human malignant glioma cells from hypoxia-induced cell death
by Ronellenfitsch, Michael W and Brucker, Daniel P and Burger, Michael C and Wolking, Stefan and Tritschler, Felix and Rieger, Johannes and Wick, Wolfgang and Weller, Michael and Steinbach, Joachim P
Brain (London, England : 1878), ISSN 0006-8950, 6/2009, Volume 132, Issue 6, pp. 1509 - 1522
Hypoxia | Glioma | Metabolism | EGFR | MTOR | Neurosciences | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Fundamental and applied biological sciences. Psychology | Vertebrates: nervous system and sense organs | Neurology | Biological and medical sciences | Development. Senescence. Regeneration. Transplantation | Medical sciences | Cell Hypoxia - drug effects | Cell Hypoxia - physiology | Protein Kinases - genetics | Glioma - enzymology | Antibiotics, Antineoplastic - pharmacology | Ribosomal Protein S6 Kinases, 70-kDa - metabolism | Ribosomal Protein S6 Kinases, 70-kDa - antagonists & inhibitors | Humans | Enzyme Inhibitors - pharmacology | Gene Silencing | Membrane Potential, Mitochondrial - drug effects | Sirolimus - pharmacology | Glioma - metabolism | Fas Ligand Protein - pharmacology | Cell Death - physiology | Signal Transduction - drug effects | Adenosine Triphosphate - metabolism | Glioma - pathology | Protein Kinases - physiology | Receptor, Epidermal Growth Factor - antagonists & inhibitors | TOR Serine-Threonine Kinases | Cell Death - drug effects | Tumor Cells, Cultured | Receptor, Epidermal Growth Factor - physiology | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial
by Wick, Wolfgang, Prof and Platten, Michael, Prof and Meisner, Christoph, PhD and Felsberg, Jörg, MD and Tabatabai, Ghazaleh, MD and Simon, Matthias, MD and Nikkhah, Guido, Prof and Papsdorf, Kirsten, MD and Steinbach, Joachim P, Prof and Sabel, Michael, MD and Combs, Stephanie E, MD and Vesper, Jan, MD and Braun, Christian, MD and Meixensberger, Jürgen, Prof and Ketter, Ralf, MD and Mayer-Steinacker, Regine, MD and Reifenberger, Guido, Prof and Weller, Michael, Prof and for the NOA-08 Study Group of the Neuro-oncology Working Group (NOA) of the German Cancer Society and German Canc Soc and NOA-08 Study Group of Neuro-oncology Working Group (NOA) of German Cancer Society
The lancet oncology, ISSN 1470-2045, 2012, Volume 13, Issue 7, pp. 707 - 715
Hematology, Oncology and Palliative Medicine | Life Sciences & Biomedicine | Oncology | Science & Technology | Astrocytoma - radiotherapy | Promoter Regions, Genetic | Dacarbazine - therapeutic use | Humans | DNA Repair Enzymes - genetics | Isocitrate Dehydrogenase - genetics | Male | Brain Neoplasms - drug therapy | Antineoplastic Agents, Alkylating - therapeutic use | Disease-Free Survival | DNA Methylation | DNA Modification Methylases - genetics | Tumor Suppressor Proteins - genetics | Astrocytoma - drug therapy | Dacarbazine - analogs & derivatives | Aged, 80 and over | Female | Aged | Brain Neoplasms - mortality | Brain Neoplasms - radiotherapy | Astrocytoma - mortality | Care and treatment | Oncology, Experimental | Radiation | Aged patients | Research | Antineoplastic agents | Radiotherapy | Biometry | Antimitotic agents | Chemotherapy | Nuclear radiation | Gliomas | Product development | Temozolomide | Cancer | Tumors | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Phase II-study of sequential high-dose-chemotherapy with paclitaxel, ifosfamide, carboplatin, etoposide( P-ICE) in patients with relapsed or refractory germ cell tumors (GCT)
by Kegel, Thomas and Cygon, Franziska and Meinert, Fabian Maximilian and Hammad, Khaled and Steinbach, Frank and Seseke, Florian and Schmoll, Hans-Joachim
Journal of clinical oncology, ISSN 0732-183X, 05/2017, Volume 35, Issue 15_suppl, pp. 4552 - 4552
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Bevacizumab for patients with recurrent multifocal glioblastomas
by Burger, Michael C and Breuer, Stella and Cieplik, Hans C and Harter, Patrick N and Franz, Kea and Bähr, Oliver and Steinbach, Joachim P
International journal of molecular sciences, ISSN 1661-6596, 11/2017, Volume 18, Issue 11, p. 2469
Multifocal | Anti-angiogenic therapy | Infiltration | Glioblastoma | Invasive growth | Bevacizumab | Biochemistry & Molecular Biology | Physical Sciences | Chemistry | Life Sciences & Biomedicine | Chemistry, Multidisciplinary | Science & Technology | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Bevacizumab - administration & dosage | Humans | Middle Aged | Neoplasm Recurrence, Local - drug therapy | Male | Neoplasm Recurrence, Local - pathology | Disease-Free Survival | Magnetic Resonance Imaging | Angiogenesis Inhibitors - administration & dosage | Glioblastoma - diagnostic imaging | Antibodies, Monoclonal, Humanized - administration & dosage | Neoplasm Recurrence, Local - diagnostic imaging | Glioblastoma - pathology | Adult | Camptothecin - administration & dosage | Female | Aged | Glioblastoma - drug therapy | Camptothecin - analogs & derivatives | Therapy | Nuclear magnetic resonance--NMR | Brain cancer | Patients | Survival | Cancer therapies | Irinotecan | Magnetic resonance imaging | Antiangiogenics | Medical prognosis | Lesions | Index Medicus | invasive growth | bevacizumab | anti-angiogenic therapy | glioblastoma | infiltration | multifocal
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Gene suppression of transketolase-like protein 1 (TKTl1) sensitizes glioma cells to hypoxia and ionizing radiation
by Heller, Sonja and Maurer, Gabriele D and Wanka, Christina and Hofmann, Ute and Luger, Anna-Luisa and Bruns, Ines and Steinbach, Joachim P and Rieger, Johannes
International journal of molecular sciences, ISSN 1661-6596, 08/2018, Volume 19, Issue 8, p. 2168
Pentose phosphate pathway | Hypoxia | Transketolase-like protein 1 | Glioma | Metabolism | Radiation | Biochemistry & Molecular Biology | Physical Sciences | Chemistry | Life Sciences & Biomedicine | Chemistry, Multidisciplinary | Science & Technology | RNA, Small Interfering - genetics | Reactive Oxygen Species - metabolism | Cell Survival | Hypoxia-Inducible Factor 1, alpha Subunit - genetics | Humans | Gene Expression Regulation, Neoplastic | Gene Silencing | Radiation Tolerance - genetics | Oxygen - metabolism | Gene Knockdown Techniques | Glioma - metabolism | Glioma - genetics | Hypoxia-Inducible Factor 1, alpha Subunit - metabolism | Transketolase - metabolism | Cell Line, Tumor | Glucose - metabolism | Transketolase - genetics | Cell Hypoxia - genetics | RNA, Small Interfering - metabolism | Radiation, Ionizing | Hypoxia-inducible factors | Pentose phosphate | Deprivation | Oxygen | Phenotypes | Reactive oxygen species | Tumor cells | Transketolase | Radioresistance | Survival | Impact analysis | Proteins | Ionizing radiation | Cell death | Antiangiogenics | Glioma cells | Pentose | Irradiation | Tumors | Index Medicus | hypoxia | glioma | metabolism | transketolase-like protein 1 | radiation | pentose phosphate pathway
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text CAR-Engineered NK Cells for the Treatment of Glioblastoma: Turning Innate Effectors Into Precision Tools for Cancer Immunotherapy
by Burger, Michael C and Zhang, Congcong and Harter, Patrick N and Romanski, Annette and Strassheimer, Florian and Senft, Christian and Tonn, Torsten and Steinbach, Joachim P and Wels, Winfried S
Frontiers in immunology, ISSN 1664-3224, 11/2019, Volume 10, pp. 2683 - 2683
Life Sciences & Biomedicine | Immunology | Science & Technology | Care and treatment | Killer cells | Brain tumors | Immunotherapy | Development and progression | Drug therapy | Glioblastoma multiforme | Cancer | Index Medicus | natural killer cells | chimeric antigen receptor | adoptive cancer immunotherapy | glioblastoma | NK-92
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights